UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): ~~December~~January 1724, ~~2010~~2011

YOUBLAST GLOBAL, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-52363	74-2820999
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

81 Greene Street, 4th Floor

New York, New York 10012

(Address of principal executive offices) (zip code)

(212) 465-3428

(Registrant's telephone number, including area code)

Copies to:

David J. Sorin, ~~CPA,~~ Esq.

SorinRoyerCooper LLC

Two Tower Center Blvd.

East Brunswick, NJ 08816

Phone: (732) 839-0400

Fax: (732) 393-1901

(Former name, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 15.~~01 Entry~~02. ~~Into~~Departure aof ~~Material~~Directors ~~Definitive~~or ~~Agreement~~Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

OnEffective ~~December~~as 17of January 24, ~~2010~~2011, YouBlast Global, Inc., a Delaware corporation (the “Company”), ~~entered~~appointed ~~into~~Dwayne anDeslatte ~~Omnibus~~to ~~Amendment~~serve ~~and~~as ~~Waiver~~a ~~Agreement~~director (of the ~~“Agreement”)~~Company’s ~~with~~board ~~Philmore~~of ~~Anderson,~~directors. Mr. ~~IV,~~Deslatte ~~John~~was ~~Thomas~~appointed ~~Bridge~~to &fill ~~Opportunity~~the ~~Fund,~~sixth LP and ~~John~~sole ~~Thomas~~vacant ~~Bridge~~position &on ~~Opportunity~~the ~~Fund~~board IIof directors, LPformerly ~~(each~~held aby ~~“Holder”~~Mr. ~~and~~Joseph ~~together~~Scharf ~~the~~until ~~“Holders”)~~December 7, 2010. Mr. ~~Anderson~~Deslatte ~~currently~~ is a ~~director~~stockholder of the Company, ~~Executive~~holding ~~Chairman~~3,334 ~~and~~shares ~~substantial~~of ~~shareholder~~common stock of the Company, 30and was formerly the chief executive officer and sales director of Mac Filmworks, Inc.~~55%~~, a corporation which merged into the Company in September 2008.

~~Pursuant~~Mr. toDeslatte ~~the~~is ~~Agreement,~~41 ~~the~~years ~~Company~~old and ~~the~~has ~~Holders~~significant ~~amended~~corporate ~~the~~experience, ~~maturity~~including ~~dates~~prior experience with a predecessor of ~~all~~the ~~outstanding~~Company. Mr. ~~debt~~Deslatte ~~instruments~~has ~~issued~~served as ofthe ~~December~~Director ~~17,~~of ~~2010,~~Operations byfor the ~~Company~~National toEagles ~~each~~and ofAngels ~~the~~Association ~~Holders~~since ~~(the~~2009 ~~“Debentures”)~~and tohas beworked ~~the~~as ~~earlier~~a ofprivate ~~(a)~~consultant ~~April~~in ~~20,~~business ~~2011,~~development orand ~~(b)~~project ~~the~~management ~~consummation~~with byprivate ~~the~~and ~~Company~~public ofcompanies ansince ~~equity~~2003. From ~~financing~~2004 ~~transaction~~through ~~with~~2007, ~~gross~~Mr. ~~proceeds~~Deslatte toserved ~~the~~as ~~Company~~Vice President of ~~not~~Business ~~less~~Research ~~than~~and ~~$3,000,000~~Analysis ~~(an~~of ~~“Equity~~SH ~~Financing~~Celera ~~Event”)~~Capital Corporation. ~~Also~~In ~~pursuant~~2004, toMr. ~~the~~Deslatte ~~Agreement,~~served on the ~~Company~~Board ~~and~~of ~~each~~Directors ~~Holder~~of ~~waived~~Spartan ~~any~~United ~~defaults~~Industries, orwhich ~~breaches~~was ofrenamed ~~any~~PharmaFrontiers ~~terms~~after ~~and~~a ~~conditions~~merger with a company of the ~~Company~~same ~~under~~name. Mr. ~~the~~Deslatte ~~Debentures~~continued ~~(and~~as ~~any~~a ~~purchase~~director ~~agreements,~~of ~~warrants,~~PharmaFrontiers orthrough ~~other~~its ~~transaction~~merger ~~documents~~with ~~related~~Opexa ~~thereto~~Pharmaceuticals, now Opexa Therapeutics (OPXA: NASDAQ). From ~~that~~October ~~may~~2007 bethrough ~~deemed~~September to2008, ~~occur~~Mr. orDeslatte ~~continue~~served ~~prior~~as toCEO anof ~~Equity~~YouBlast’s ~~Financing~~predecessor, ~~Event~~MAC Filmworks, Inc.

Mr. Deslatte is a registered nurse. In ~~consideration~~2007, he served on the staff of the ~~foregoing~~Pediatric ~~waivers~~Intensive Care Unit at St. Joseph’s Hospital in Phoenix, Arizona, and, ~~amendments~~in 2007 through 2009, ~~the~~he ~~Company~~worked ~~granted~~at ~~each~~John ~~Holder~~C. ~~the~~Lincoln ~~right~~Hospital towith ~~receive,~~trauma ~~upon~~and anorthopedic ~~Equity~~patients. Mr. ~~Financing~~Deslatte ~~Event,~~holds ~~payment~~a B.A. in ~~full~~history offrom ~~all~~Texas ~~principal~~A&M University and ~~interest~~a ~~due~~B.S. ~~under~~in ~~the~~nursing, ~~Debentures~~cum tolaude, ~~which~~and M.B.A. from Texas Women’s University. Mr. Deslatte served in the ~~Holder~~Corps isof aCadets ~~party~~for four years while at Texas A&M University.

~~The~~There ~~foregoing~~is ~~description~~no offamily ~~the~~relationship ~~Agreement~~between ~~does~~Mr. ~~not~~Deslatte ~~purport to be complete~~ and is ~~qualified~~any inother ~~its~~executive ~~entirety~~officer byor ~~reference~~director toof the ~~Agreement~~Company, ~~which~~or isperson ~~attached~~nominated asor anchosen ~~exhibit~~by tothe ~~this~~Company ~~Current~~to ~~Report~~become ~~and~~an isexecutive ~~incorporated~~officer byor ~~reference herein~~director.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet

Arrangement of a Registrant.

See Item 1.01.

Item 9.01 Financial Statements and Exhibits.

Exhibit Number			Description
99.1			Omnibus Amendment and Waiver Agreement, dated December 17, 2010, between the Company and the Holders.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	YOUBLAST GLOBAL, INC.
Dated: December 20, 2010	By:	/s/ Jeffrey Forster
Dated: January 31, 2011	By:	/s/ Jeffrey D. Forster
		Name: Jeffrey Forster
		Name: Jeffrey D. Forster
		Title: Chief Executive Officer

Filing Compare · YOUBLAST GLOBAL, INC.